Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda.

BMC infectious diseases - 27 Dec 2012

Reynolds Steven J, Sendagire Hakim, Newell Kevin, Castelnuovo Barbara, Nankya Immaculate, Kamya Moses, Quinn Thomas C, Manabe Yukari C, Kambugu Andrew

Abstract excerpt

BACKGROUND: Viral load monitoring (VLM) to identify individuals failing antiretroviral therapy (ART) is not widely available in resource-limited settings. We compared the genotypic resistance patterns between clients with VLM versus immunological monitoring (IM). METHODS: Between 2004-2008, 559 ART naïve clients were enrolled in a prospective cohort, initiated on ART, and monitored with viral load (VL) and CD4+...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to HIV Infections

Share to Uganda

Source

Open in PubMed Open full text

Identifiers

PMID: 23270482
DOI: 10.1186/1471-2334-12-381
PMCID: PMC3548731

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda.PMID 23270482Read ↗

HIV-1 Drug Resistance Among Ugandan Adults Attending an Urban Out-Patient Clinic.Semantic proximity Read ↗

High frequency of HIV-1 drug resistance among individuals with persistent low-level viremia during first-line antiretroviral therapy in Uganda.Semantic proximity Read ↗

Evolution of drug resistance during 48 weeks of zidovudine/lamivudine/tenofovir in the absence of real-time viral load monitoring.Semantic proximity Read ↗

Pretreatment HIV drug resistance predicts accumulation of new mutations in ART-naïve Ugandan children.Semantic proximity Read ↗

Resistance to antiretroviral therapy among patients in Uganda.Semantic proximity Read ↗

Antiretroviral drug resistance profiles and response to second-line therapy among HIV type 1-infected Ugandan children.Semantic proximity Read ↗

Low drug resistance levels among drug-naive individuals with recent HIV type 1 infection in a rural clinical cohort in southwestern Uganda.Semantic proximity Read ↗

Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children.Semantic proximity Read ↗

Development of phenotypic and genotypic resistance to antiretroviral therapy in the UNAIDS HIV Drug Access Initiative--Uganda.Semantic proximity Read ↗

Evolution of drug resistance after virological failure of a first-line highly active antiretroviral therapy regimen in Uganda.Semantic proximity Read ↗

Prospective long-term outcomes of a cohort of Ugandan children with laboratory monitoring during antiretroviral therapy.Semantic proximity Read ↗

High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.